Eternity Healthcare gets Health Canada OK for needle-free injection device

By Admin
Share
Eternity Healthcare Inc has secured Health Canada clearance for its needle-free injection device, the Comfort-in ®". The medical techno...

Eternity Healthcare Inc has secured Health Canada clearance for its needle-free injection device, the Comfort-in ®".  The medical  technology company is in the process of filing the documentation for the FDA’s approval in the U.S.,  the media reports said.  

The needle free injection device is a unique technology  that uses a high pressure infusion system that delivers fluid to the body similar to a needle. This technology has  proved to be effective in administering more than 95% of medicine into the skin in less than a second. 

The device is suitable for patients suffering from diabetes to inject insulin.  It can also be used to inject other types of medicines for a vast variety of diseases and patients  and also for painless vaccination.   

Eternity Healthcare is a publicly listed company in the U.S. and is also a leader in medical technologies possessing state-of-the-art medical devices including diagnostic kits, digital cholesterol readers, and injection-free needles.  

The company also sells its products to healthcare professionals for the use in clinical laboratories, physicians’ offices, pharmacies and to consumers through companies that provide diagnostic  information.  

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma